Dr. Reznichek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 W Carson St
Harbor-Ucla Med. Ctr., Box 5
Torrance, CA 90502Phone+1 310-222-2724Fax+1 310-222-2856
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1965 - 1970
Northwestern University The Feinberg School of MedicineClass of 1964
Certifications & Licensure
CA State Medical License 1965 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Intranasal Fentanyl as an Analgesic for Cystoscopic Procedures Start of enrollment: 2009 May 01
- Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 1 citationsEstablishing Synoptic Cancer Pathology Reporting in Low- and Middle-Income Countries: A Nicaraguan Experience.Darling Valverde L, Richard C Reznichek, Magdaly Torres S
JCO Global Oncology. 2022-02-01 - 17 citationsThe role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.Abhishek Karnwal, Rose Venegas, Brian Shuch, Jeffrey C. Bassett, Jacob Rajfer
The Canadian Journal of Urology. 2010-04-01 - 33 citationsSurveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.Jonathan Bergman, Richard Reznichek, Jacob Rajfer
BJU International. 2007-09-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
